Clinical Trials List
Protocol Number87801493LYM1001
Completed
2025-08-01 - 2025-09-09
Phase I
Terminated2
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chien-Chin Lin Division of Others -
- Chieh-Lung Cheng Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- HSIN-AN HOU Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- MEI-FANG CHENG Division of Nuclear Medicine
- Wen-Chien Chou Division of Others -
- 袁章祖 Division of Others
- 劉高郎 Division of Radiology
- 李思慧 Division of Family Medicine
- MING YAO Division of General Internal Medicine
- 楊鎰聰 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Ching Lin Division of Radiology
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
140 participants
